These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Management of the immunobullous disorders. II. Pemphigus. Huilgol SC; Black MM Clin Exp Dermatol; 1995 Jul; 20(4):283-93. PubMed ID: 8548984 [TBL] [Abstract][Full Text] [Related]
6. [Prolonged complete clinical remission in patients with severe pemphigus vulgaris after cycles of intravenous cyclophosphamide]. España Alonso A; Panizo C; Fernández S; Marquina M; Pretel M; Aguado L; Sánchez-Ibarrola A Actas Dermosifiliogr; 2009 Mar; 100(2):113-20. PubMed ID: 19445875 [TBL] [Abstract][Full Text] [Related]
7. [Comparative study on the treatment of pemphigus]. De Backer J Arch Belg Dermatol Syphiligr; 1971; 27(1):89-98. PubMed ID: 5126851 [No Abstract] [Full Text] [Related]
8. Effect of plasmapheresis therapy on circulating levels of pemphigus antibodies. Tan-Lim R; Bystryn JC J Am Acad Dermatol; 1990 Jan; 22(1):35-40. PubMed ID: 2298963 [TBL] [Abstract][Full Text] [Related]